Buphenine: Difference between revisions
Appearance
Content deleted Content added
removed Category:Phenols; added Category:4-Hydroxyphenyl compounds using HotCat |
Adding page to Category:Cerebral vasodilators as requested at WP:AFC/C (afcrc-helper) |
||
Line 68: | Line 68: | ||
{{cardiovascular-drug-stub}} |
{{cardiovascular-drug-stub}} |
||
{{genito-urinary-drug-stub}} |
{{genito-urinary-drug-stub}} |
||
[[Category:Cerebral vasodilators]] |
Latest revision as of 14:37, 24 October 2024
Clinical data | |
---|---|
Trade names | Arlidin |
Other names | Nylidrin |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.531 |
Chemical and physical data | |
Formula | C19H25NO2 |
Molar mass | 299.414 g·mol−1 |
3D model (JSmol) | |
|
Buphenine, also known as nylidrin and sold under the brand name Arlidin, is a β2 adrenoreceptor agonist[1] that acts as a vasodilator.[2]
It was developed as a chemical derivative of oxilofrine, and first reported in the literature in 1950.[3]
See also
[edit]References
[edit]- ^ Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest Ophthalmol Vis Sci. 26 (2): 163–9. PMID 2857689. Archived from the original on 2013-04-15.
- ^ Freedman L (1955). "Arlidin: a new vasodilative sympathomimetic drug". Angiology. 6 (1): 52–8. doi:10.1177/000331975500600106. PMID 14350296. S2CID 46317963.
- ^ Külz F, Schneider M (1950). "Über neue gefäßerweiternde Sympathomimetika" [On new vasodilative sympathomimetics]. Klin Wochenschr (in German). 28 (31–32): 535–7. doi:10.1007/BF01481535. PMID 14775050.